Unlikely Collaborators has made a significant monetary investment in SIY Global, kicking-off a partnership that will see the two companies working together in a myriad of ways, including product and curriculum development, teacher training, and content creation.
Researchers at MedStar Health, Brigham and Women's Hospital, and the University of Utah found electronic health record (EHR) vendor misconduct may have led to widespread use of suboptimal products for more than 70,000 clinicians across the country, as published today in JAMA Health Forum.
Hyperproof, a pioneer in SaaS based security and compliance operations management, announced today the release of a suite of new functionality to help global enterprise organizations operating in complex environments manage their risks and compliance programs at scale.
Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced that its phase 2 clinical trial of RSLV-132 in patients with long covid has been fully enrolled (NCT04944121).
Despite centuries of research, treating and curing cancer remains an urgent health research priority. With generous support from anonymous donors, the GastroIntestinal Research Foundation (GIRF) has launched a bold initiative, CA CURE, to identify and fund research to improve diagnostics and develop therapeutics focused on immunotherapies and personalized vaccines.
Somatus, the nation's leading and largest value-based kidney care company, has received a 2022 Validation Program Report certifying the claim that kidney disease patients who receive Somatus Transition of Care Assessment (TCA) services have fewer hospital readmissions than similar patients who do not receive TCA services.
The Alzheimer's Clinical Trial Consortium (ACTC) will be presenting analyses of screening plasma and neuroimaging data from the AHEAD Study at CTAD in November.
MIM Software Inc., a leading global provider of medical imaging software, announced today it has received approval from Health Canada for its AI auto-contouring solution, Contour ProtégéAI™.
W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease.
ScienceMedia has joined Biocom California at the Provider level of membership, connecting to more than 1,700 member companies and 500,000 employees across California and beyond.
The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader in care guidance, today announced the three finalists for the 2022 Hearst Health Prize, a $100,000 award given in recognition of excellence in data science for managing or improving health in the U.S.
United BioChannels (UBC), a commercial strategy consultancy, announced its acquisition of ORFLO Technologies, LLC, from Gemini Bioproducts.
School-based telehealth provider releases impact report following one year of dramatic expansion during the nation's youth mental health crisis.
Xtremis, LLC (Xtremis), a Nashville-based startup developing advanced, Artificial Intelligence control systems that improve the performance of wireless networks in congested RF environments, recently announced its intention to relocate to Morgantown, WV.
COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system for the treatment of autoimmune disorders (COUR NanoParticles or CNPs), today announced that the U.S. Food and Drug Administration has cleared an Investigational New Drug (IND) application to initiate a Phase 1b/2a proof-of-concept study of COUR's investigational therapy, CNP-106.
Process-innovation leader ImageSource, Inc. has rolled out a new flagship website at ImageSourceInc.com.
Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no available therapies, today announced two upcoming poster presentations showing data on the company's lead clinical candidate, VS-041, a selective matrix metalloprotease (MMP) inhibitor for treatment of heart failure with preserved ejection fraction (HFpEF) and the discovery of novel calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) inhibitors for treatment of β-blocker resistant arrythmias, at the American Heart Association (AHA) Scientific Sessions November 5 – 7 in Chicago, IL.
The Vilcek Foundation announces the recipients of the 2023 Vilcek Foundation Prizes. Awarded annually in the arts and sciences, the prizes recognize and celebrate immigrant contributions to the arts, culture, and society, and build awareness of how important immigration is for intellectual and cultural life in the United States.
GQR Global Markets announced today that it has been named #7 on Staffing Industry Analysts' (SIA) 2022 List of Fastest-Growing Staffing Firms for the 5th year in a row. Even more exceptional is the fact that GQR is the only firm to rank in the top ten for four of the last five years and within the top sixteen every year for the last five years.
Riverside Oral Surgery, the premier oral and maxillofacial surgery group in New Jersey, has been named one of the Best Places to Work (medium market employer) in 2022 by NJBIZ.
Partnership will deliver healthcare education and resources to an estimated 27.7 million members of the African- American and Latino communities on a multitude of therapeutic areas and disease states.
It's likely many Americans think of September as the start of football season or the beginning of a new school year.
Retrace, a leader in dental artificial intelligence and provider of digital infrastructure for U.S. healthcare, announces the publication, "A generative adversarial inpainting network to enhance prediction of periodontal clinical attachment level" in the August 2022 Edition of the Journal of Dentistry.
Lactose-reduced infant formula made with corn syrup solids was associated with higher obesity risk among Special Supplemental Nutrition Program for Women, Infants and Children (WIC) participants in Southern California, according to a new study by researchers from Public Health Foundation Enterprises (PHFE) WIC, a program of Heluna Health; and Children's Hospital Los Angeles.
The American Physical Society (APS), publisher of the prestigious Physical Review journals, has appointed Rachel Burley as its first Chief Publications Officer (CPO). In this new role, Burley will manage more than a dozen leading peer-reviewed journals.
Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced today the commencement of U.S. pivotal clinical trials for its eQUANT system, which will be used to support a submission for FDA clearance.
The National Policing Institute (the Institute) is proud to announce and welcome Robin S. Engel, PhD as the Institute's Senior Vice President, becoming the second highest-ranking executive within the national non-profit research and policy organization dedicated to excellence in policing and community safety through science and innovation.
As has been demonstrated by many studies, contoured prism has historically shown efficacy in relieving symptoms as a therapeutic offering.
YourBio Health, Inc., developers of the world's first painless push-button blood collection device, was identified as a key contributor in the recent preprint published report in medRxiv.
ImageSource, Inc., the leader in process-innovation, has completed the company's move into a new headquarters location at 3003 Sunset Way SE in Tumwater, WA.
Industry leaders collaborating to expand advanced operating room technology, infrastructure solutions for hospitals, surgical centers.
Stuart Therapeutics, Inc. (Stuart), a clinical stage company developing advanced ophthalmic therapeutics, announced today that the United States Patent and Trademark office has issued a Notice of Allowance in each of two patent applications associated with the company's clinical product candidates, including ST-100, Stuart's drug candidate for the treatment of dry eye disease (DED) which recently completed a successful Phase 2 trial.
Stuart Therapeutics, Inc. (Stuart), a clinical stage company headquartered in Stuart, Florida that is developing advanced ophthalmic therapeutics, announced today the results of its Type C Guidance meeting with the U.S. Food and Drug Administration (FDA) regarding the continued development plan for ST-100, Stuart's first drug candidate for the treatment of Dry Eye Disease (DED) in humans.
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial
Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, will host a live stream discussion between Arsham Sheybani, MD of Washington University and Lori Pacheco, RN, CRNO of Orbis International.
CEFALY Technology has partnered with Ordergroove, the leader in Relationship Commerce, to offer an upgraded electrode subscription experience to its customers.
MIM Software, Inc has been awarded a Top Workplaces 2022 honor by the cleveland.com and The Plain Dealer Top Workplaces.
The in-space propulsion firm Busek Co. confirmed its supply of BHT-350 Hall effect thrusters for a range of missions supported by Airbus OneWeb Satellites (AOS).
CampViews EMR is a mobile application for iOS and Android devices that provides Diabetes camps with a registration system, a camper's individual profile and digital log with real-time DexCom CGM data and trends. CampViews is changing the way diabetes camps are run.
ByHeart, the next-generation baby nutrition company dedicated to setting a new standard for infant nutrition, today announced the publication of an article in the Journal of Pediatric Gastroenterology and Nutrition entitled, "Effects of a novel high-quality protein infant formula on energetic efficiency and tolerance: a randomized trial.
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today announced it has been awarded a Small Business Innovation Research (SBIR) grant funded by USDA's National Institute of Food and Agriculture (NIFA) to build a rapid, portable, quantitative test to detect many Per- and Polyfluoroalkyl Substances (PFAS) simultaneously.
Nyquist Data, Inc., the leading intelligence platform for medical technology, announces today that it has entered into a commercial partnership with Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation.
Orpyx® Medical Technologies Inc. (Orpyx), a digital health company focused on extending the health span of patients with diabetes, announced the launch of the Orpyx SI® Flex Sensory Insole system and Orpyx Remote Patient Monitoring (RPM) services.
WellBe Senior Medical is accelerating its growth and delivery of in-home medical care across the nation through several key additions to the WellBe Executive Leadership Team. The new leadership additions will focus on scaling WellBe's footprint with a focus on the patient experience.
As Migraine and Headache Awareness Month kicks off, CEFALY Technology is celebrating its 8th anniversary in the United States and a major milestone: 2 billion migraines treated with the CEFALY migraine treatment device.
Evolution Research Group, LLC (ERG), a privately held, independent pharmaceutical services provider focused on neuroscience announced the acquisition of Ohio Clinical Trials (OCT), a 64-bed phase 1 unit in Columbus, OH, that specializes in the execution of human abuse potential (HAP) studies, as well as other highly complex early phase trials including pain modeling, qEEG/EEG, respiratory depression, and alcohol interaction, among others.
MOBILion Systems Inc. is teaming up with its industry partners, including Agilent Technologies and Protein Metrics, to deliver a series of educational events at the 70th Annual American Society for Mass Spectrometry (ASMS) conference being held June 5th to June 9th in Minneapolis, Minnesota.
CEC Oncology, the oncology arm of CE Concepts, LLC (CEC) and a subsidiary of KnowFully Learning Group, announces four abstracts accepted for publication in the Professional Development and Education Advances track of the 2022 ASCO Annual Meeting (https://conferences.asco.org/am/attend #ASCO22).
Initial data results, detailed in a preprint manuscript, currently under peer review, to be shared by Hopelab at the 2022 Association for Psychological Science (APS) Convention, May 27, 2022
Tens of thousands of people travel yearly to the Super Bowl to take in the festivities and have a great time, but new data reveals they should be careful of a prevalent STD.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right